Neovascular changes after pegaptanib in diabetics

Ophthalmology. 2007 Mar;114(3):615-6. doi: 10.1016/j.ophtha.2006.10.009.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aptamers, Nucleotide / therapeutic use*
  • Diabetic Retinopathy / drug therapy*
  • Humans
  • Randomized Controlled Trials as Topic
  • Retinal Neovascularization / drug therapy*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Aptamers, Nucleotide
  • Vascular Endothelial Growth Factor A
  • pegaptanib